Company Analysis
Sign in

Cellyan Biotechnology Co., Ltd (HKPD)

Nasdaq: HKPD · Wholesale-Drugs, Proprietaries & Druggists' Sundries · filing with the SEC since 2024
Full chart Alerts Compare
Grade5.5
◀ Past 5.5● Present 5.4▶ Future 5.7
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in March.

The Form 20-F filed Aug 7, 2026 for the period ended Mar 31, 2026 is not in EDGAR's company facts yet; its figures here are that filing's own, read from the SEC's financial statement data sets.

Income statement, by fiscal year, newest first
Fiscal yearFY 2026FY 2025FY 2024FY 2023
Period endingMar 31, 2026Mar 31, 2025Mar 31, 2024Mar 31, 2023
Report filedAug 7, 2026Aug 14, 2025··
Revenue13,433,50720,313,81816,688,36412,555,991
Cost of revenue12,047,19817,898,65913,129,6999,817,066
Gross profit1,386,3092,415,1593,558,6652,738,925
Selling, general and administrative2,395,0752,215,8591,889,4551,758,080
Operating income-2,386,538-2,284,587-1,954,442-1,791,361
Finance costs133,84997,66782,76623,242
Finance income4541,741474219
Net finance income (costs)-133,395-95,926-82,292-23,023
Other gains and losses8,537-68,728-64,987-33,281
Income before income taxes-1,128,29736,1121,525,9691,020,770
Income tax expense7,66663,168196,25222,574
Net income-1,135,963-27,0561,329,717998,196
Net income to shareholders-1,135,963-27,0561,329,717998,196
Net income to ordinary shareholders·-27,0561,329,717998,196
Earnings per share, basic-0.069-0.0030.180.146
Earnings per share, diluted-0.069-0.0030.180.146
Weighted average shares, basic16,349,98610,205,4797,365,5706,843,000
Weighted average shares, diluted16,349,98610,205,4797,365,5706,843,000
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldifrs-full:Revenue
Cost of revenue what it cost to make or buy what it soldifrs-full:CostOfSales
Gross profit revenue less the cost of what it soldifrs-full:GrossProfit
Selling, general and administrative the cost of selling and of running the companyifrs-full:SellingGeneralAndAdministrativeExpense
Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities
Finance costs what its borrowing costifrs-full:FinanceCosts
Finance income what its cash and investments earnedifrs-full:FinanceIncome
Net finance income (costs) interest earned less interest paid, outside the businessifrs-full:FinanceIncomeCost
Other gains and losses gains and costs outside the businessifrs-full:OtherGainsLosses
Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax
Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations
Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss
Net income to shareholders the profit or loss that belongs to the company's shareholdersifrs-full:ProfitLossAttributableToOwnersOfParent
Net income to ordinary shareholders what is left for common shareholdersifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity
Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare
Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare
Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares
Weighted average shares, diluted the average count with every share that could be issuedifrs-full:AdjustedWeightedAverageShares
SI Assistanton HKPD · research, not advice